FindA University Ltd Featured PhD Programmes
Engineering and Physical Sciences Research Council Featured PhD Programmes
University of Sheffield Featured PhD Programmes
FindA University Ltd Featured PhD Programmes
FindA University Ltd Featured PhD Programmes
"pharmacology"×
10 miles

Molecular Biology (pharmacology) PhD Projects, Programs & Scholarships

We have 32 Molecular Biology (pharmacology) PhD Projects, Programs & Scholarships

  • "pharmacology" ×
  • Molecular Biology×
  • clear all
Order by 
Showing 1 to 30 of 32
  Molecular Pharmacology of N-Methyl-D-aspartate glutamate receptors
  Dr P Chen
Applications accepted all year round

Funding Type

PhD Type

Fast neuronal communication at synaptic contacts relies on neurotransmitter release from the presynaptic terminal and the majority of excitatory neurotransmission within the mammalian central nervous system is mediated by the neurotransmitter glutamate.
  Pharmacology of soft nanomaterials: investigating nanoparticle-cell interaction
  Dr M Jones
Applications accepted all year round

Funding Type

PhD Type

Research into so-called ’soft’ or organic nanomaterials has been thriving with a wide variety of compositions being explored for pharmaceutical applications.
  Call for Applications to 9 PhD programmes at the University of Brescia, Italy

Funding Type

PhD Type

Call for Applications to 9 PhD programmes at the University of Brescia, Italy. The University of Brescia offers a wide range of opportunities in the following 9 programmes across different research areas.
  Quantitative Allele-Specific Proteomics in Drug Metabolism and Disposition
  Dr J Barber, Dr B Achour, Prof A Rostami
Applications accepted all year round

Funding Type

PhD Type

The effective dose of a drug is subject to considerable inter-individual variation because the enzymes that metabolise drugs and the proteins that transport them in and out of cells exist, in many cases, in different polymorphic forms and are expressed in varying concentration.
  London Interdisciplinary Biosciences Consortium (LIDo)

Funding Type

PhD Type

 LIDo is an exciting collaboration between UCL, Kings College London, Queen Mary, Birkbeck, Royal Veterinary College and London School of Hygiene and Tropical Medicine, six of London's world-class universities and specialist institutions.
  London Interdisciplinary Biosciences Consortium (LIDo)

Funding Type

PhD Type

 LIDo is an exciting collaboration between UCL, Kings College London, Queen Mary, Birkbeck, Royal Veterinary College and London School of Hygiene and Tropical Medicine, six of London's world-class universities and specialist institutions.
  London Interdisciplinary Biosciences Consortium (LIDo)

Funding Type

PhD Type

 LIDo is an exciting collaboration between UCL, Kings College London, Queen Mary, Birkbeck, Royal Veterinary College and London School of Hygiene and Tropical Medicine, six of London's world-class universities and specialist institutions.
  Mass spectrometric imaging of biological tissues
  Prof J Preisler, Ms M Machalkova
Application Deadline: 31 October 2019

Funding Type

PhD Type

Mass spectrometry imaging (MSI) exploits the ability of mass spectrometry to identify molecules according to their specific mass and image their distribution across the sample.
  Join a new graduate school at the interface of biology and computation: IMPRS-BAC in Berlin

Funding Type

PhD Type

We are looking for outstanding graduates from all over the world - whether you have a degree in bioinformatics, computer science, mathematics, physics, molecular biology or something related, as long as you have a passion for solving biological questions through computational methods, the IMPRS-CBSC may be the PhD program for you.
  London Interdisciplinary Biosciences Consortium (LIDo)

Funding Type

PhD Type

 LIDo is an exciting collaboration between UCL, Kings College London, Queen Mary, Birkbeck, Royal Veterinary College and London School of Hygiene and Tropical Medicine, six of London's world-class universities and specialist institutions.
  Molecules, Cells and Organisms - Nottingham and Rothamsted BBSRC Doctoral training Partnership

Funding Type

PhD Type

University of Nottingham & Rothamsted Research BBSRC Doctoral Training Partnership. Four year PhDs available in the research area Molecules, Cells and Organisms -Starting October 2019.
  London Interdisciplinary Biosciences Consortium (LIDo)

Funding Type

PhD Type

 LIDo is an exciting collaboration between UCL, Kings College London, Queen Mary, Birkbeck, Royal Veterinary College and London School of Hygiene and Tropical Medicine, six of London's world-class universities and specialist institutions.
  London Interdisciplinary Biosciences Consortium (LIDo)

Funding Type

PhD Type

 LIDo is an exciting collaboration between UCL, Kings College London, Queen Mary, Birkbeck, Royal Veterinary College and London School of Hygiene and Tropical Medicine, six of London's world-class universities and specialist institutions.
  Overcoming drug resistance in cancer using nano-encapsulated combination therapies
  Dr M Jones
Applications accepted all year round

Funding Type

PhD Type

Despite advances in cancer treatment, the development of drug resistance remains a major issue affecting long term patient survival.
  Therapeutic resolution of Myodysplastic Syndrome (MDS)
  Research Group: Pharmacology and Experimental Therapeutics
  Dr T Nasim, Dr K Pors
Applications accepted all year round

Funding Type

PhD Type

Myelodysplastic syndromes (MDS) are the most common adult myeloid malignancy in the UK and it has been estimated that around 8,000 and 40,000 new cases are diagnosed each year in the UK and USA, respectively.
  Extracellular Matrix Abnormalities in Cardiac Insulin Resistance as a Therapeutic Target of Chronic Heart Failure
  Dr L Kang, Prof C Lang
Applications accepted all year round

Funding Type

PhD Type

Description. Diabetes and chronic heart failure (CHF) often coexist such that each condition may affect the other in terms of causation and outcome.
  How does the vascular matrix environment influence platelet activation?
  Dr S Calaminus
Application Deadline: 31 March 2020

Funding Type

PhD Type

The platelet is a blood cell that plays a key role in the prevention of bleeding. For platelets to form a clot or thrombus effectively, they must rearrange their actin cytoskeleton to withstand high shear stress from blood flow in the arteries.
  Identification of novel glucose-dependent alterations responsible for vascular dysfunction in Type 2 diabetes.
  Prof Tim Palmer, Dr R Sturmey
Application Deadline: 31 March 2020

Funding Type

PhD Type

Diabetes is a growing global healthcare problem. The majority of people living with diabetes have Type 2 diabetes mellitus (T2DM), characterised by a resistance of the body to the action of insulin.
  Modulation of platelet-mediated innate immune responses in chronic lymphocytic leukaemia
  Dr M Arman
Application Deadline: 31 March 2020

Funding Type

PhD Type

Chronic lymphocytic leukaemia (CLL) is the most common form of leukaemia in the Western World. B-cell receptor-induced intracellular signals are critical for the survival of leukaemia cells and disruption of this pathway by the Bruton’s tyrosine kinase (Btk) inhibitor ibrutinib is a highly effective CLL therapy.
  Precision-cut lung slices to investigate the effect of human rhinovirus on cough and airway inflammation
  Dr L Sadofsky
Application Deadline: 31 March 2020

Funding Type

PhD Type

The human Rhinovirus (RV) is the major cause of the common cold. There are no current treatments or vaccines for the virus other than over the counter preparations to alleviate symptoms.
  Re-purposing diabetes medicines to manage bleeding complications in myeloproliferative neoplasms.
  Prof Tim Palmer, Dr D Allsup
Application Deadline: 31 March 2020

Funding Type

PhD Type

Myeloproliferative neoplasms (MPNs) are a group of three related blood cancers in which the bone marrow overproduces one of the three cellular components of blood (erythrocytes, leukocytes and platelets).
  Analysing the factors that regulate expression of blood-brain barrier drug transporter proteins
  Dr J L Penny, Dr C Demonacos
Applications accepted all year round

Funding Type

PhD Type

In order to treat diseases associated with the central nervous system (CNS), e.g. cancer, Parkinson’s disease, depression, it is essential for therapeutic drugs to be able to penetrate into the brain.
  Investigating the role of bioactive lipids in skin health
  Prof A Nicolaou, Prof C A O'Neill
Applications accepted all year round

Funding Type

PhD Type

Human skin depends on systemic provision of fatty acids that are important to maintain the integrity of the epidermal barrier as well as to support the associated immune and inflammatory reactions.
  Molecules, Cells and Organisms - Nottingham and Rothamsted BBSRC Doctoral training Partnership

Funding Type

PhD Type

University of Nottingham & Rothamsted Research BBSRC Doctoral Training Partnership. Four year PhDs available in the research area Molecules, Cells and Organisms -Starting October 2019.
  Myocardial biology with a specific focus on the mechanisms underlying cardiac fibrosis and atrial fibrillation
  Dr S Reilly, Assoc Prof M Lei
Application Deadline: 26 July 2019

Funding Type

PhD Type

Using a combination of extensive cell culture and molecular biology techniques, and functional cellular assays to understand molecular mechanisms underlying myocardial structural and electrical remodelling associated with atrial fibrillation.
  Novel strategies for the diagnosis and treatment of snakebites
  Dr S Vaiyapuri
Applications accepted all year round

Funding Type

PhD Type

Snakebites represent a major neglected tropical disease affecting several million people worldwide and resulting in as many as 150000 deaths each year.
  Modelling of Oral Neutrophil Epithelial interactions
  Dr E Hagi-Pavli
Applications accepted all year round

Funding Type

PhD Type

Background and Clinical Significance. Neutrophils are an important and vital cellular component of the innate immune system providing rapid protection against microbial invasion.
  New Dimensions in Cannabinoid Receptor 2 Therapeutic Development: Exploring Spatial and Temporal Signalling Bias
  Dr N Grimsey
Applications accepted all year round

Funding Type

PhD Type

Compounds derived from Cannabis sativa, termed “cannabinoids”, primarily exert their effects via two G protein-coupled receptors (GPCRs), Cannabinoid Receptors 1 and 2 (CB1 and CB2).
  Climate Change Solutions: Developmental Programming of Fish Thermal Tolerance Limits
  Dr G Galli, Dr H Shiels
Applications accepted all year round

Funding Type

PhD Type

Climate change poses a significant threat to global biodiversity. Conservation strategies are critically dependent on a thorough understanding of the effects of fluctuating environments on animal morphology, physiology and behaviour.
  Epigenetic mechanisms of behavioural, placental and cognitive impairment in a neurodevelopmental model for schizophrenia
  Dr R Hager, Prof J Neill, Dr J Glazier
Applications accepted all year round

Funding Type

PhD Type

A fundamental question in disease research is how stressors experienced during critical developmental periods influence the genesis or ‘programming’ of adult disease (Estes & McAllister 2016).
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.